Telomir Pharmaceuticals Inc TELO Q4 2025 Earnings Wider Than Expected Loss Highlights PreRevenue Challenges SKWD Q1 2026 Earnings EPS Surges Past Estimates Despite Limited Revenue Disclosure Voyager Therapeutics Q1 2026 Earnings EPS Beats Estimates as Stock Rises Amid Pipeline Progress CEG Q1 2026 Earnings EPS Beats Estimates by 568 as Stock Declines Over 4 SGLY Q3 2019 Earnings EPS Misses Estimates Sharply Amidst Continued Operational Headwinds Exelon EXC Holds Steady Near 46 as Utility Sector Provides Stability Hancock Whitney HWC Edges Higher Near Resistance as Regional Banking Sector Stabilizes Syndax Pharmaceuticals SNDX Holds Steady Near 20 as Market Watches Key Levels PIMCO Access Income Fund PAXS Holds Steady as Market Awaits Direction DBGI Q3 2023 Earnings Significant Loss Per Share Amid Stock Decline